“Ceremed is committed to the design and development of unique medical polymers
to enhance the effectiveness of surgical procedures,”
- Tadeusz Wellisz, M.D., CEO of Ceremed.
Our culture of innovation encompasses robust R&D, development of innovative material combinations and advanced medical devices. Our extensive experience allows us to move quickly from concept to device approval.

Partnerships with medical device manufacturers and research institutions enables Ceremed to provide advanced polymer-based devices that meet the needs of the medical market place. Our R&D capabilities are focused on providing innovative, market-leading solutions that enable rapid development of advanced medical devices including novel biomaterials.

Applications Under Development for AOC PolymerBlend™

The following applications are under development and have not been submitted, reviewed or approved by the U.S. FDA and are not used in humans.

  1. Expanded indications for its current product line. Drug delivery applications for small molecule therapeutics such as antibiotics and anti-neoplastic agents.
  2. Delivery system for large molecules, proteins, and biologics.
  3. Development of lubricants and lubricious coatings to facilitate surgical instrumentation and implant placement.
  4. Coatings for orthopedic implants made of materials such as ceramics, porous polymers and porous metals.
  5. Acute and chronic wound management including the delivery of topical therapeutics.

Applications Under Development

    Resorbable porous membranes

    BIOPOR® implant material

    Implantable cell preservation technology

    Dural repair systems

    Adhesion barriers

Intellectual Property Position

    The family of AOC PolymerBlend™ products is protected by extensive intellectual property positions both in the USA and internationally.




©2011 Ceremed, Inc. All rights reserved. D00049 Rev C